Agenus Q4 net loss $46.8M; targets annual cash burn of ~$50M by mid-2025

AGENUS INC

Q4 2024 net loss $46.8M ($2.04/share); full-year net loss $232.3M ($10.59/share).
Revenue Q4 $26.8M, full-year $103.5M (largely non-cash royalty).
Cash balance $40.4M at Dec 31, 2024, down from $76.1M year-end 2023.
Operational cash burn $28.7M in Q4; plan to cut annualized burn to ~$50M by mid-2025.
BOT/BAL program shows durable responses in colorectal cancer; partnership discussions ongoing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.